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HypertrophyMyostatin (MSTN) functions as a negative regulator of skeletal muscle mass. In mammals, MSTN-deﬁcient
animals result in an increase of skeletal muscle mass with both hyperplasia and hypertrophy. A MSTN gene
is highly conserved within the ﬁsh species, allowing speculation that MSTN-deﬁcient ﬁsh could exhibit a dou-
ble-muscled phenotype. Some strategies for blocking or knocking downMSTN in adult ﬁsh have been already
performed; however, these ﬁsh show either only hyperplastic or hypertrophic growth in muscle ﬁber. There-
fore, the role of MSTN in ﬁsh myogenesis during post-hatch growth remains unclear. To address this ques-
tion, we have made MSTN-deﬁcient medaka (mstnC315Y) by using the targeting induced local lesions in a
genome method. mstnC315Y can reproduce and have the same survival period as WT medaka. Growth
rates of WT and mstnC315Y were measured at juvenile (1–2 wk post-hatching), post-juvenile (3–7 wk
post-hatching) and adult (8–16 wk post-hatching) stages. In addition, effects ofMSTN on skeletalmuscle differen-
tiation were investigated at histological and molecular levels at each developmental stage. As a result,mstnC315Y
show a signiﬁcant increase in body weight from the post-juvenile to adult stage. Hyper-morphogenesis of
skeletal muscle in mstnC315Y was accomplished due to hyperplastic growth from post-juvenile to early
adult stage, followed by hypertrophic growth in the adult stage. Myf-5 and MyoD were up-regulated in
mstnC315Y at the hyperplastic growth phase, while myogenin was highly expressed in mstnC315Y at the
hypertrophic growth phase. These indicated that MSTN in medaka plays a dual role for muscle ﬁber develop-
ment. In conclusion, MSTN in medaka regulates the number and size of muscle ﬁber in a temporally-controlled
manner during posthatch growth.oshiura@fra.affrc.go.jp
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Myostatin (MSTN) or growth and differentiation factor-8 (GDF-8)
is amember of the transforming growth factor-β (TGF-β) superfamily,
and functions as a negative regulator of skeletal muscle mass
(McPherron et al., 1997). MSTN-null mice generated by gene targeting
show a drastic and widespread increase in skeletal muscle with acombination of hyperplasia and hypertrophy. Each muscle of mutant
mice weighs 2–3 times compared to those of wild-type mice. Natural-
ly occurring mutations in the MSTN gene have been identiﬁed in dou-
ble-muscling cattle breeds (Kambadur et al., 1997; McPherron and
Lee, 1997), dogs (Mosher et al., 2007) and even humans (Schuelke et
al., 2004). MSTN protein is synthesized in skeletal muscle as a propep-
tide, which is processed by proteolytic cleavage to produce themature
form at the C-terminus. The C-terminal homodimer is known to be the
biologically active molecule. The C-terminal amino acid sequence is
highly conserved across mammalian and avian species (McPherron
and Lee, 1997). Their identities are 95–100% among mouse, rat,
human, porcine, chicken, turkey, baboon, bovine and ovine. Further-
more, in ﬁsh (for example, zebraﬁsh, Atlantic salmon, sea perch, Euro-
pean seabass, bastard halibut and Chilean ﬂounder), the C-terminal
domain reaches identities higher than 88% comparing with mammali-
an MSTN (Delgado et al., 2008). According to these studies, there is a
high possibility that the MSTN gene and its biological function should
be conserved in vertebrates.
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strated inconsistent phenotypes in body weight. Lee et al. (2009)
reported that MSTN knock-down zebraﬁsh using vector-based RNA
interference exhibited a 1.4-fold increased body weight at 4 months.
In contrast, Xu et al. (2003) showed that over-expression of MSTN
prodomain as a dominant-negative form in zebraﬁsh resulted in an
only slightly increased body weight at 2.5 months. Sawatari et al.
(2010) also revealed that over-expression of a dominant-negative
form of MSTN in medaka did not change the body weight at
6 months. Therefore, it remains unclear whether blocking the MSTN
function in ﬁsh leads to body weight gain. These reports also show
conﬂicting phenotypes in muscle ﬁbers. MSTN knock-down zebraﬁsh
resulted in only hypertrophy, while the over-expression of dominant-
negative forms in zebraﬁsh and medaka affected only hyperplasia.
It is quite possible that these seemingly contradictory phenotypes in
ﬁbers are due to the incomplete inhibition of the MSTN signaling
pathway. Thus, previous morphological evidence could not have
demonstrated whether MSTN plays an inhibitory role in hyperplastic
or hypertrophic muscle growth in ﬁsh. To accurately understand
the MSTN function in ﬁsh, the generation of a completely MSTN-
suppressed ﬁsh is required. Moreover, there is an important consider-
ation in the evaluation of muscle growth in ﬁsh. Hyperplasia and hy-
pertrophy in ﬁsh can continue during posthatch growth (Johnston,
1999; Rowe and Goldspink, 1969); however, in the studies reported
previously, the effects of MSTN on myogenesis have been analyzed
at single or a few points, but not throughout life. Therefore, there is
some possibility that change of phenotypes is overlooked in transgen-
ic ﬁsh for vector-based RNA interference and MSTN prodomain over-
expression. To address these problems, further studies has been re-
quired using other techniques, which is able to completely inhibit
MSTN function during posthatch growth.
In the current study, we made medaka with a MSTN deﬁcient sig-
naling pathway (called MSTN deﬁcient medaka or mstnC315Y in the
present report), corresponding to the naturally occurring mutation
in double-muscled Piedmontese cattle (Kambadur et al., 1997), by
targeting induced local lesions in the genome (TILLING) method
(Taniguchi et al., 2006). mstnC315Y have the ability to reproduce
and have the same survival period as WT medaka. These ﬁsh have
allowed analysis of the effects of MSTN on myogenesis throughout
life. As a result, the mstnC315Y shows a double-muscling phenotype
with hyperplasia and hypertrophy. Moreover, we elucidated that
MSTN in medaka regulated the number of muscle ﬁbers at the post-
juvenile stage and the size of those at the adult stage. Therefore,
mstnC315Y mutant medaka provides an opportunity to elucidate the
MSTN function in ﬁsh.
Materials and methods
Cloning of medaka MSTN gene
RNA was extracted from wild-type medaka larvae (Kyoto-Cab, a
substrain of Cab) by RNeasy® Mini Kit (QIAGEN Sciences, MD, USA)
according to the manufacturer's instructions. cDNA was synthesized
using PowerScript (BD Biosciences Clontech, Palo Alto, CA, USA). To
identify medaka MSTN gene orthologs, we used the basic local align-
ment search tool (BLAST) to search the medaka genome database
(http://www.ensembl.org/Oryzias_latipes/blastview). Medaka MSTN
cDNA sequences were then determined using a combination of RT-
PCR and rapid ampliﬁcation of cDNA ends (RACE). RACE products
were generated using SMARTTM RACE cDNA Ampliﬁcation Kit (BD
Biosciences Clontech). The 5′ RACE (1st: 5′-AGATCTTCACCTCAAT-
GAACGGTTGCAG-3′, nest: 5′-TCTGCTGAGGTGACGGCTAAGTCATTTC-3′)
and 3′ RACE primers (1st: 5′-GACGAGCATGCATCTACGGAGACAATTA-
3′, nest: 5′-ATGGAGAGCCAAAGTGTTGCCTTTTCTC-3′) were used. The
cDNA sequence was used to retrieve the genomic sequence from the
draft medaka genome assembly.Generation of MSTN mutant medaka
Generation of MSTN mutant medaka was carried out as described
previously (Taniguchi et al., 2006). To ﬁnd the mutations in the re-
gion of interest, the third exon of the medaka MSTN gene was
screened using the forward primer #1 (5′-GGACAGCTGCCAAA-
TAGTGC-3′) and reverse primer #1 (5′-AGGCTGACTGCTGCCTCTAC-
3′) by PCR (92 °C for 60 s; 12 cycles of 92 °C for 20 s, 65 °C for 20 s
with a decrement of 0.6 °C per cycle, 72 °C for 30 s; 20 cycles of
92 °C for 20 s, 58 °C for 20 s and 72 °C for 30 s; 72 °C for 180 s [ABI
9700 dual 384 well GeneAmp PCR system]). The PCR products were
treated with an ExoSAP-IT kit (GE Healthcare). Sequencing reaction
was then carried out using a BigDye terminator ver. 3 kit (Applied
Biosystems) and the forward primer #1. Sequencing products cleaned
up by ethanol precipitation were run on automated ABI 3730xl DNA
analyzers (Applied Biosystems). In vitro fertilization was carried out
using sperm with the desired mutation and the progeny were geno-
typed by sequencing. Heterozygous ﬁsh carrying the same mutation
were back-crossed with wild-type medaka, at least 4 times. To verify
the genotype from this incross, the DNA was ampliﬁed by PCR with
forward primer #2 (5′-TCAGGAGAAGTAGGCAGCTGTG-3′) and re-
verse primer #2 (5′-CATGGAGGGGATCTTACCGTAG-3′). The 546-bp
PCR product obtained was sequenced using the forward primer #3
(5′-ATGAGACCCTGACAGCCATC-3′). The resulting sequence chro-
matograms were analyzed for the expected single nucleotide poly-
morphism (guanine-to-adenine replacement) at one or both alleles
(Fig. 2A). Wild-type ﬁsh (WT) and homozygous mutant line
(mstnC315Y) obtained from the incross of heterozygous mutant par-
ents were used for all the following experiments.
Nuclear protein preparation
Nuclear extract was prepared using the modiﬁed protocol previ-
ously described by (Lizotte et al., 2005). Skeletal muscle was frozen
with liquid nitrogen and crushed into a ﬁne powder. The obtained
powder (200 mg) was mixed in 3 ml of the lysis buffer containing
50 mM Tris (pH 7.5), 250 mM NaCl, 5 mM EDTA, 0.1% NP-40, 1 mM
NaF and 1:20 protease inhibitor cocktail (Complete Mini EDTA free,
Roche Diagnostics K. K., Basel, Switzerland), and was homogenized
at low speed for 1 min using a mechanical homogenizer (Physcotron
NS-310E, Microtec Co., Ltd., Japan). The homogenate was centrifuged
at 450×g and 4 °C for 15 min to remove tissue debris. The superna-
tant was mixed in an equal volume (3 ml) of the isotonic solution
consisting of 10 mM Hepes (pH 7.5), 1.5 mM MgCl2, 10 mM KCl,
0.5 mM dithiothreitol (DTT), 1 mM NaF and 1:20 protease inhibitor.
Nuclei were pelleted by centrifugation at 2000×g and 4 °C for
15 min. The pellet was resuspended in the hypertonic solution con-
sisting of 300 mM Hepes (pH 7.5), 30 mM MgCl2, 1.4 M KCl, 0.5 mM
DTT, 1 mM NaF and 1:20 protease inhibitor. To allow the nuclei to
shrink, the resuspension was incubated on ice for 20 min. These
were then centrifuged at 2000×g and 4 °C for 15 min. The ﬁnal pellet
was resuspended in the storage solution containing 20 mM Hepes
(pH 7.5), 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT,
25% (v/v) glycerol, 1 mMNaF and 1:20 protease inhibitor. The protein
concentration was determined with the BCA Protein Assay (Pierce, IL,
USA).
SDS-PAGE and western blotting
Nuclear proteins were separated by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE). This technique was per-
formed using 4% (w/v) acrylamide stacking gel followed by a 5–20%
gradient separation gel. Proteins were transferred to a PVDF mem-
brane (0.2 μm Pall Fluoro Trans® W membranes, Pall Corp., MI,
USA). Firstly, the membrane was washed with TBS (20 mM Tris–
HCl, pH 7.5, 150 mM NaCl) for 5 min and then blocked with blocking
AB
Fig. 1.Medaka MSTN proﬁles. (A) Genome structure of medakaMSTN gene (3551 bp). White boxes indicate each exon (with the Greek numeral representing the number of exon)
and bars represent each intron. (B) Sequence alignment of bovine and Kyoto-Cab medaka MSTN protein. Amino acids conserved across the two species are outlined in red. The
medaka MSTN amino-acid sequence has a 61.3% identity to bovine MSTN. The C-terminal protein, which is an active peptide, is outlined in light blue. The medaka C-terminal region
has an 88.1% identity to bovine MSTN. Black triangles in panels A and B indicate the amino acid responsible for the phenotype in this study.
84 S. Chisada et al. / Developmental Biology 359 (2011) 82–94solution (1% ECL plus Blocking Agent [GE Healthcare Co., Ltd., UK] in
TBS containing 0.05% (v/v) Tween20) for 1 h at room temperature
(RT). The blocking solution was also used as dilution solutions forh
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containing 0.05% (v/v) Tween 20 for 20 min. Immunoreactive bands
were detected with the secondary antibody (HRP-conjugated goat
anti-rabbit IgG antibody, GE) and ECL detection reagent (GE)
according to the manufacturer's instructions. Chemiluminescent sig-
nal was visualized by exposing to hyperﬁlm ECL (GE). TGF-β treated
Mv1Lu cell lysates (Santa Cruz Biotechnology, Inc., CA, USA) were
used as a positive control for phosphorylated Smad2 protein.
Equal loading of the proteins was conﬁrmed with an anti-histone
H2B antibody.
Fish husbandry
Medaka (Oryzias latipes) were maintained in aerated freshwater
under a 14 h light/10 h dark photoperiod at a water temperature of
27±1 °C. In this condition, they sexually matured and spawned
daily. Eggs were incubated in 0.0001% methylene blue until they
hatched. Hatched larvae were transferred to a petri dish (diameter;
90 mm) and fed with paramecium. At 7–10 day after hatching,
they were transferred to each plastic rearing container (2 L or 5 L)
and fed with newly hatched Artemia nauplii and commercial pow-
der feeds for ﬁsh fry from juvenile to adult. Feeding was carried
out ﬁve times a day, so that all ﬁsh experienced ad libitum food
availability.
Growth evaluation
Ten breeding pairs in WT and mstnC315Y groups were randomly
chosen and reared in plastic rearing containers. Approximately 300
eggs in each group were obtained simultaneously. Of hatched larvae
in each group, 200 larvae were reared until 5 wk post-hatching as de-
scribed above. After 5 wk post-hatching, ﬁsh were transferred to large
tanks (150 L) to avoid adverse effects of the rearing density on
growth. Fish in both groups were fed the same amount at the same
time throughout the experimental period. To analyze growth rates
in WT and mstnC315Y, both of standard length and body weight
were measured according to the following procedure. Ten ﬁsh were
randomly sampled from each group at 1, 2, 3, 4, 5, 7, 9, 12, and
16 wk post-hatching. After 7 wk post-hatching (sexually mature),
all samplings were conducted to have an equal sex ratio (5 males
and 5 females) in consideration of the sexual difference in the growth.
Fish were anesthetized using 0.003% eugenol (FA100, Tanabe Seiyaku
Co., Ltd., Japan) and photographed using a digital microscope (Focus-
Studio 1400, Nakaden Co., Ltd., Japan). Standard length (SL: the length
of a ﬁsh measured from the tip of the snout to the posterior end of the
last vertebra) was measured from the captured digital image using
image analysis software (Image-Pro® Plus v4.5.1, Media Cybernetics,
Inc., MD, USA). For the purpose of measuring body weight (BW), BD
Falcon cell strainer tubes (Becton Dickinson Co., NJ, USA) were used.
Fish were individually put on nylon membrane of cell strainer (BD).
The tubes were brieﬂy centrifuged at 1500×g for 1 min; from these
results the extra water on the body surface was removed under the
same conditions, and body weight could be accurately measured.
Condition factor (K) was calculated as BW/SL3×102 (BW: body
weight in mg, SL: standard length in mm).
Quantitative PCR analysis
Gene expression analysis of myogenic regulatory factors (MRFs:
MyoD, Myf5, and myogenin) in skeletal muscle was performed with
quantitative PCR as described in the MIQE guidelines (Bustin et al.,
2009). Skeletal muscle was sampled from three individuals of
mstnC315Y and WT at four different developmental stages (2, 5, 8,
and 16 wk post-hatching) from juvenile to adult as representatives
for gene expression analysis. After ﬁsh were anesthetized using
0.003% eugenol, all ﬁns and the head containing the operculumwere cut off, and then the abdominal viscera were removed from
ﬁsh. Skeletal muscle was immediately ﬁxed using RNAlater solution
(Ambion, Austin, TX, USA) for 5 h at room temperature. From 2 wk
post-hatching ﬁsh, whole skeletal muscle (approximately 1.0 mg) was
stored in RNAlater solution. From 5, 8, and 16 wk post-hatching, muscu-
lar portion containing the anus (approximately 20 mg) was removed
and stored in RNAlater solution. Total RNAwas extracted usingRNeasy®
Mini Kit (QIAGEN) and RNA in the extracted samples was quantiﬁed
using spectrophotometry (NanoDrop, Thermo Scientiﬁc). Genome
DNA elimination and reverse transcription was performed with the
extracted samples containing 500 ng total RNA using QuantiTect® Re-
verse transcription Kit (QIAGEN) according to the manufacturer's pro-
tocol. Quantitative PCR was performed in a total of 25 μl containing
12. 5 μl of SYBR® Premix EX TaqTM (Takara Bio Inc., Shiga, Japan), 0.5 μl
of ROX Reference Dye II (Takara), 150 ng of cDNA (1 μl of 1:10 dilution
of the reverse transcription) as a template, and each primer at a ﬁnal
concentration of 0.2 μM. Using Primer3 programs on the web (source
code available at http://fokker.wi.mit.edu/primer3/), primer sets for
the quantitative PCR of medaka MRFs were designed in the nucleotide
sequence ofmedakaMyoD (Ensembl Gene ID: ENSORLG00000000694),
Myf5 (Ensembl Gene ID: ENSORLG00000016257), and myogenin
(Ensembl Gene ID: ENSORLG00000015906) on the Ensembl Genome
Browser (http://www.ensembl.org). The primer sets and amplicon
sizes were as follows, Myf5: 5′-CTGAGCCTGGAAGTCCTCTGTC-3′
and 5′-GGCTGTCTTGTTGTCCAAACTC-3′, yielding a fragment of
137 bp;MyoD: 5′-CTCCAACTGCTCTGACGGAAT-3′ and 5′-ACTGGAGAC-
GACGGAGCTG-3′, yielding a fragment of 142 bp; myogenin: 5′-TCAAC-
CAGCAGGACACAGAGAC-3′ and 5′-CACCAACACTCAGAAGATCCTC-3′,
yielding a fragment of 186 bp. MRFs mRNA levels were normalized
by EF-1α with primer set (5′-CTGCAGGACGTCTACAAAATCG-3 and
5′-TGGTTCAGGATGATGACCTGAG-3′’ , yielding a fragment of 299 bp)
as the reference gene. The fragment length of each sample was checked
by agarose gel electrophoresis. Each PCR reaction in the quantitative
PCR analysis was conducted in triplicate with an initial denaturation
step of 10 s at 95 °C followed by an ampliﬁcation of the target cDNA
(40 cycles at 95 °C for 5 s and 60 °C for 20 s) using Mx3005P Real-
timeQPCR System (Stratagene, CA, USA). In thismethod, PCR-efﬁciency
was calculated using the standard curve generated by plotting the
threshold cycle vs. the known dilution of each PCR product (Myf5,
102.4%; MyoD, 98.6%; myogenin, 102.7%; EF-1α, 100.0% ampliﬁcation
efﬁciency). This allowed conﬁrmation of the validity of each primer
set in this analysis. There was no difference in EF-1αmRNA expression
betweenmstnC315Y andWTmedaka at each developmental stage. The
results are presented as changes in relative expression normalized
to the reference gene using the 2−(ΔΔCt) method described by (Pfafﬂ,
2001).
Histological analysis
Skeletal muscle was sampled from three individuals of mstnC315Y
and WT at four different developmental stages (2, 5, 8, and 16 wk
post-hatching) from juvenile to adult as representatives for histolog-
ical analysis. Each sample was ﬁxed in Davidson's ﬁxative solution
(33% EtOH, 22% formalin, and 11.5% acetic acid in distilled water
(DW)) for 24 h at RT. After washing twice with DW, samples were
decalciﬁed by EDTA solution containing 50 mM Tris (pH 8.3) and
400 mM EDTA for 24 h at RT and dehydrated, parafﬁn-embedded
using Leica EG 1160 (Leica Microsystems, Germany), and serially sec-
tioned at 4 μm thickness using Leica RM2145 (Leica). The sections
were mounted on glass slides (Superfrost® micro slide glass, Matsu-
nami Co., Ltd., Japan) covered with egg albumen and stained with
Mayer's hematoxylin (Sigma-Aldrich, Inc., MO, USA) and eosin
(Wako, Co., Ltd., Japan). Cross section at the position of pelvic ﬁns
was used for counting the number of muscle ﬁbers. Counting area
was described in Fig. 5A. Cellularity was calculated as the number of
ﬁbers per cross-sectional muscle area, and used for evaluating ﬁber
10 mm
A B
Fig. 3.Morphology of WT and mstnC315Y medaka. (A) Side (upper) and overhead (under) view of WT. (B) Side (upper) and overhead (under) view of mstnC315Y. Double-headed
arrows show height and width of body. mstnC315Y exhibited higher and wider body trunk than WT. Both medaka were sampled at 16 wk post-hatching. Scale bar; 10 mm.
86 S. Chisada et al. / Developmental Biology 359 (2011) 82–94size. The lower cellularity means that each ﬁber in a cross section is
larger. The muscle area was measured from the captured digital
image using Image-Pro® Plus v4.5.1.A
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Fig. 4. Growth curves from juvenile to adult stage. Measurement of body weight (BW),
standard length (SL) and condition factor (K) as growth indices in WT (black triangles)
and mstnC315Y (white squares) medaka. K value was calculated as 102×BW/SL3 for each.
Datawere sampled at 1, 2, 3, 4, 5, 7, 9, 12 and16 wkpost-hatching, respectively. (A)Growth
curveofBW for eachgroup. BWmstnC315Y signiﬁcantly increased at 5 wkpost-hatching for the
ﬁrst time (BWWT=45.2±9.4 mg, BWmstnC315Y=55.5±9.8 mg). Each BW value plateaued
at 16 wk post-hatchingwith signiﬁcant differences in bodyweight between the two groups
(BWWT=467.2±82.0 mg, BWmstnC315Y=609.4±131.2 mg). (B) Growth curve of SL for
each group. SLmstnC315Y was signiﬁcantly longer than SLWT from 5 to 16 wk post-hatching.
(C) Curve of K for each group. K values in both groups showed signiﬁcant differences
from 5 to 16 wk post-hatching. Broken lines in all panels show ﬁtted curves. The dots,
black, and broken lines under t-axis (age post-hatching) indicate the juvenile, post-juvenile
and adult stage, respectively. Values are means±SEM (n=10 per sample point in all
panels). *pb0.05, **pb0.01, and ***pb0.001, respectively.Morphological image processing for quantitative analysis of muscle ﬁber
image
The size distribution of muscle ﬁbers was analyzed based on ex-
tended morphological image processing (Kimori et al., 2007, 2010).
Original images (32-bit color images) of cross sections were ﬁrst con-
verted to 8-bit grayscale images. In order to reduce speckle noise and
to improve the signal-to-noise-ratio of images, the grayscale images
were applied to Gaussian smoothing ﬁlter. Additionally, the edges of
muscle ﬁber region were enhanced by top-hat ﬁltering (Meyer,
1979). These enhanced images were binarized by a local thresholding
method (Niblack, 1986). Muscle ﬁber regions were segmented by wa-
tershed transform (Meyer and Beucher, 1990), and then the segment-
ed region was represented as the region enclosed by a 1-pixel-wide
contour line. Finally, each region was calculated as the size of its mus-
cle ﬁber.
Immunohistochemical staining
Localization of PCNA (proliferation cell nuclear antigen)-positive
cells in muscle ﬁbers was analyzed by an immunohistochemical pro-
cedure. Coronal section of skeletal muscle was used for immunohisto-
chemical analysis of PCNA. Observed area is described in Fig. 5B. The
sections were treated with 3% H2O2 aq. for 30 min at RT, and were in-
cubated with a monoclonal mouse anti-PCNA (Clone PC10) (Thermo
Scientiﬁc, CA, USA) overnight at 4 °C. Anti-PCNA antibody was diluted
1:300 with Can Get Signal immunostain immunoreactions enhancer
solution A (Toyobo Co., Ltd., Japan). After washing twice with TBS,
sections were incubated with peroxidase-labeled anti-rabbit or anti-
mouse antibody (Histoﬁne Simplestain Max PO; Nichirei, Co., Ltd.,
Japan) for 30 min at RT. Peroxidase activity was detected with diami-
nobenzine (DAB; Sigma-Aldrich).
Statistical analysis
Data were expressed as mean±standard error of the mean (SEM).
Results were statistically evaluated for signiﬁcance using the t-test
between mstnC315Y and WT groups for all analyses of growth, ﬁber
size and number, and expression of MRF mRNAs. Differences were
considered signiﬁcant when pb0.05.
Results
Cloning of medaka MSTN
Only a single ortholog of the mammalian MSTN gene was identi-
ﬁed (by the BLAST search) in the medaka genome. The medaka
MSTN gene has 3 exons and encodes a protein consisting of 377
White Muscle
Red Muscle
a
White Muscle
b
A B
Fig. 5. Diagrams of body areas of medaka used for histological analysis. (A) Ventral cross-sectional area. Shaded gray area was used for counting ﬁber numbers and measuring mus-
cle area. Square a is shown as photographs in Fig. 6. (B) Horizontal cross-sectional area. All the area was used for immunohistochemical analysis. Square b is indicated as photo-
graphs in Fig. 10.
87S. Chisada et al. / Developmental Biology 359 (2011) 82–94amino acids (Fig. 1). The medaka MSTN amino acid sequence has a
61.3% identity to bovine MSTN. The C-terminal protein is an active
peptide. The medaka C-terminal region has an 88.1% identity with
the bovine C-terminal region.
Generation of MSTN mutant medaka
To generate MSTN mutant medaka, we targeted exon 3 of the
MSTN gene for nucleotide sequencing. We sequenced the genomes
of 5760 samples obtained from ENU-mutagenized medaka. We iden-
tiﬁed a C315Y-substituted mutant, corresponding to naturally occur-
ring mutation (C313Y) in double-muscled Piedmontese cattle
(Kambadur et al., 1997) (a black triangle in Figs. 1A and B, and under-
lined in Table 1). From the incross of heterozygous C315Y mutant
parents, we obtained the expected numbers of wild-type ﬁsh (WT),
heterozygous mutants, and homozygous mutants (mstnC315Y)
(Fig. 2A). Piedmontese cattle have a double muscled phenotype dueTable 1
List of MSTN mutations from our TILLING library showing mutated nucleotides and
resulting changes of the transcript.
DNA sequence Amino acid substitution
TGAGGTGAAG (ANG) TCTCAGAGGG I 259V
GTCCCGTTGC (TNA) GCCGCTACCC C284S
TCTGGGGAGT (GNA) TGAGTACATG C315Y
GTGTGAGTAC (ANC) TGTACTTGCA M318L
ACCCACCAAG (ANT) TGTCGCCCAT M347L
ACCCACCAAG (ANG) TGTCGCCCAT M347V
CCCATCAACA (TNC) GCTCTACTTT M352T
TAAGATCCCC (TNC) CCATGGTGGT S368P
(ANB): A is the nucleotide of wild-type Kyoto-cab and B is the nucleotide of the mutant.
There were eight types of mutation in the exon 3 and all mutations were amino acid
substitutions. The mutation we selected (C315Y) is underlined.to a point mutation in the MSTN gene causing a substitution of tyro-
sine for cysteine (C313Y) in the signaling portion of the protein. In
order to conﬁrm whether mstnC315Y have lost the MSTN function,
we examined the level of phosphorylated Smad2 in the nuclear pro-
teins from skeletal muscle between WT and mstnC315Y medaka by
western blotting. As expected, mstnC315Y had minimal phosphoryla-
tion of Smad2 in skeletal muscle whereas WT showed a distinct band
of phosphorylated Smad2 (Fig. 2B). This revealed that the mstnC315Y
mutation had blocked the MSTN signal pathway in skeletal muscle,
indicating that a point mutation in the MSTN gene causing a substitu-
tion of tyrosine for cysteine (C315Y) resulted in the loss of MSTN
function in medaka. We therefore concluded that we had succeeded
in generating MSTN-deﬁcient medaka.
Morphology and growth evaluation of MSTN mutant medaka
MSTN loss-of-function or several MSTN mutations cause increased
muscle mass in a variety of mammals. We examined the morphology
ofmstnC315Ymedaka at the adult stage. As shown in Fig. 3,mstnC315Y
medaka exhibited a higher and wider body trunk than WT, implying
that mstnC315Y medaka had an increased muscle mass. Growth rates
of WT andmstnC315Ymedaka throughout life were measured from ju-
venile to adult (juvenile stage: 1–2 wk post-hatching, post-juvenile
stage: 3–7 wk post-hatching, adult stage: 8–16 wk post-hatching) as
described in Materials and methods. There was no difference in body
weight (BW) between the two groups from 1 to 4 wk post-hatching;
however, the increasing BW in mstnC315Y accelerated from 5 wk
post-hatching up to 12 wk post-hatching, resulting that there was a
signiﬁcant difference between the two groups from 5 to 16 wk post-
hatching (Fig. 4A). At 16 wk post-hatching, mstnC315Y showed a 1.3
fold weight gain (BWmstnC315Y=609.4±131.2 mg) compared to WT
(BWWT=467.2±82.0 mg). Both growth curves of standard length
(SL) in WT and mstnC315Y were similar to each other although
mstnC315Y showed slightly higher values than WT after 5 wk post-
88 S. Chisada et al. / Developmental Biology 359 (2011) 82–94juvenile stage (Fig. 4B). Since the increase of BWmstnC315Ymight be con-
sidered due to an increase of SLmstnC315Y, condition factors (K=102×
BW/SL3) were used. Fig. 4C showed that KmstnC315Y values wereA
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Fig. 7. Cellularity as an indicator of muscle ﬁber size. A quantitative analysis for the size
of muscle ﬁber in WT (black columns) andmstnC315Y (white columns) medaka. Cellu-
larity was calculated as the number of ﬁbers/cross-sectional muscle area. Measurement
area is described in Fig. 5A. Lower cellularity indicates a larger size in muscle ﬁber.
There was minimal difference in cellularity between WT andmstnC315Y in the juvenile
and post-juvenile stage, while cellularity in mstnC315Y was lower than that in WT in
the adult stages. Values are means±SEM (n=3, at all sample points). ***pb0.001.
89S. Chisada et al. / Developmental Biology 359 (2011) 82–94Loss of MSTN function induces hypertrophy of muscle ﬁbers in skeletal
muscle during the adult stage
To elucidate the effect of deﬁcient MSTN on skeletal muscle, we
performed histological observations and two quantitative analyses
of muscle ﬁbers in skeletal muscle of WT and mstnC315Y medaka.
At the microscopic level, there was seemingly no difference in ﬁber
size between the two groups at juvenile (2 wk post-hatching,
Figs. 6A and B) and post-juvenile stages (5 wk post-hatching,
Figs. 6C and D). At the late adult stage (16 wk post-hatching,
Figs. 6G and H), muscle ﬁbers of mstnC315Y were visibly larger than
those of WT. Next, cellularity (muscle ﬁber density) was used for a
quantitative comparison of ﬁber size. Lower values of cellularity
mean that each ﬁber in a cross section is larger. Fig. 7 shows thatb
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Fig. 8. Distribution analysis of muscle ﬁber area. Quantitative analysis for cross-sectional ﬁb
ﬁber area was measured at juvenile (A), post-juvenile (B), early adult (C), and late adult (
panels show median values of ﬁber area of WT and mstnC315Y, respectively. At the juven
of FAWT=282.1 μm2, median value of FAmstnC315Y=250.0 μm2). At the post-juvenile stage,
FAWT=727.5 μm2,median value of FAmstnC315Y=718.4 μm2). At the adult stage,median values of
value of FAmstnC315Y=2008.4 μm2 at the early adult stage; median value of FAWT=1627.8 μm2bm
repeated analysis using another ﬁsh of WT andmstnC315Y at each developmental stage.there was little difference in cellularity between WT and mstnC315Y
at the juvenile and post-juvenile stages, suggesting that at these
stages the ﬁbers were the same size. Although the difference in
ﬁber size at the early adult stage (8 wk post-hatching) was difﬁcult
to explain by only microscopic observations, cellularities demonstrat-
ed a statistically-signiﬁcant difference in ﬁber size between the two
groups at this stage. The cellularity in mstnC315Y at the early adult
stage exhibited a signiﬁcantly lower value than that inWT (Fig. 7), in-
dicating that mstnC315Y at this stage had larger sized muscle ﬁbers
than WT. At the late adult stage, the lower cellularity supported that
hypertrophy was induced in muscle ﬁbers of mstnC315Y at this
stage. The size of each muscle ﬁber was further analyzed using anoth-
er method. The morphological image processing can provide quanti-
tative analysis of muscle ﬁber size by measuring each ﬁber area
(FA). Fig. 8 shows one pair of comparisons of the distribution and me-
dian value of FA between WT and mstnC315Y. At the juvenile and
post-juvenile stages, median values of FA in mstnC315Y were not
higher than WT (median value of FAWT=282.1 μm2, median value
of FAmstnC315Y=250.0 μm2 at the juvenile stage; median value of
FAWT=727.5 μm2, median value of FAmstnC315Y=718.4 μm2 at the
post-juvenile stage). Maximum areas ofmstnC315Ywere much larger
than those of WT (max FAWT=993.0 μm2, max FAmstnC315Y=
1556.1 μm2 at the juvenile stage; max FAWT=3054.5 μm2, max
FAmstnC315Y=3754.6 μm2 at the post-juvenile stage), while the num-
ber of small ﬁbers in mstnC315Y were more than that in WT. There-
fore, muscle ﬁber development in mstnC315Y did not exhibit
marked hypertrophy compared to that in WT at the juvenile and
post-juvenile stages, although ﬁber size in both WT and mstnC315Y
medaka was growing at the juvenile and post-juvenile stages. At
the early and late adult stages, there was a large difference in the
median values of FA between WT and mstnC315Y (median value of
FAWT=1607.1 μm2, median value of FAmstnC315Y=2008.4 μm2 at the
early adult stage; median value of FAWT=1627.8 μm2, median value
of FAmstnC315Y=2186.3 μm2 at the late adult stage). Furthermore, the
ﬁber area distributions of mstnC315Y shifted to the right of WT atb
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er area in WT (gray columns) and mstnC315Y (white columns) medaka. Cross-sectional
D) stages, using morphological image processing. Black line a and broken line b in all
ile stage, median value of FA in mstnC315Y was lower than that in WT (median value
median value of FA in mstnC315Y was about the same value as WT (median value of
FA inmstnC315Ywere larger than those inWT (median value of FAWT=1607.1 μm2bmedian
edian value of FAmstnC315Y=2186.3 μm2 at the late adult stage). The result was conﬁrmed by
90 S. Chisada et al. / Developmental Biology 359 (2011) 82–94these stages. These results clearly show that the muscle ﬁber size of
mstnC315Y was larger than that of WT at the adult stage. The result
from the morphological image processing was conﬁrmed by repeated
analysis using another ﬁsh of WT and mstnC315Y at each develop-
mental stage. Therefore, we conclude that loss of the MSTN function
induces hypertrophy of muscle ﬁbers in skeletal muscles at the
adult stage.
Loss of MSTN function induces hyperplasia of muscle ﬁbers in skeletal
muscle from the post-juvenile stage to early adult stage
Muscle ﬁber number in WT increased linearly up to the post-juve-
nile stage (5 wk post-hatching) and reached a plateau during the
adult stage (8 and 16 wk post-hatching), whereas that in mstnC315Y
increased up to the early adult stage (8 wk post-hatching) and
reached a plateau at the late adult stage (16 wk post-hatching)
(Fig. 9A). Furthermore, mstnC315Y had a larger number of muscle ﬁ-
bers than WT at all stages, and showed a 1.3-fold increase in ﬁber
number at the adult stage, indicating that a loss of the MSTN function
caused hyperplasia of muscle ﬁbers. The relation between SL and ﬁber
number is illustrated in Fig. 9B. Muscle ﬁber number in WT increased
linearly up to 15 mm in SL, and reached a plateau value (1912.4±
129.3 ﬁbers). Muscle ﬁber number in mstnC315Y increased approxi-
mately linearly up to 20 mm, and reached a plateau value (2551.7±
201.9 ﬁbers) with 33% increase compared to WT. At the post-juvenile
stage (15 mm in SL), muscle ﬁber number in WT reached a plateau,
whereas that in mstnC315Y was increasing linearly at this stage.
Therefore, we conﬁrmed the proliferation of myogenic cells in0
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Fig. 9.Muscle ﬁber development in number during posthatch growth. (A) Relation be-
tween the number of ﬁbers and age post-hatching for WT (black columns) and
mstnC315Y (white columns) medaka. Numbers of ﬁbers was counted in the cross-
sectional muscle area, described in Fig. 5A. The number of muscle ﬁber in mstnC315Y
was more than that in WT at all stages. Values are means±SEM (n=3, at all stages).
***pb0.001. (B) Relation between the number of ﬁbers and standard length for WT
(black triangles) and mstnC315Y (white squares). The ﬁber number of mstnC315Y per
standard length was more than that of WT throughout life. Broken line a in panel B
shows the average of plateau values in mstnC315Y (2551.7±201.9 ﬁbers), and black
line b shows that in WT (1912.4±129.3 ﬁbers).mstnC315Y by immunohistochemical analysis for proliferation cell
nuclear antigen (PCNA). At the post-juvenile stage (15 mm in SL),
mstnC315Y still have many PCNA-positive myocytes although WT
rarely have PCNA-positive myocytes (Figs. 10A and B), indicating
that in mstnC315Y, muscle cells still proliferated at the post-juvenile
stage. At the early adult stage (20 mm in SL), there is no PCNA-positive
myocytes in bothWT andmstnC315Y (Figs. 10E and F). These results in-
dicate that loss ofMSTN function induces hyperplasia ofmuscle ﬁbers in
skeletal muscle from the post-juvenile stage to early adult stage.
MSTN temporally controlled the expression of each MRF mRNA at each
developmental stage
We investigated mRNA levels of MRFs (MyoD, Myf-5, and myo-
genin) in skeletal muscle between WT and mstnC315Y. The expres-
sion of EF-1α mRNA exhibited a steady state level at each
developmental stage between WT and mstnC315Y medaka, resulting
that EF-1α was used as a reference gene. The mRNA levels of MRFs
were not signiﬁcantly different between the two groups at the juve-
nile stage (Fig. 11A). At the post-juvenile stage, Myf-5 and MyoD
mRNAs in mstnC315Y were expressed highly with increases of 3.4
times and 1.6 times, respectively, compared to WT (Fig. 11B). At the
early adult stage, Myf-5 and MyoD mRNAs in mstnC315Y were kept
at a high level as well as the post-juvenile stage, whereas myogenin
mRNA in mstnC315Y was signiﬁcantly increased and 4.4 times
higher-expressed than WT (Fig. 11C). At the late adult stage, Myf-5
and MyoD mRNAs between WT and mstnC315Y were almost the
same levels, whereas expression of myogenin mRNA in mstnC315Y
was strongly up-regulated with a 10 fold increase to WT (Fig. 11D).
These results showed that loss of the MSTN function induced a
high-level expression of Myf-5 and MyoD from the post-juvenile
stage to the early adult stage and subsequently an elevated expres-
sion of myogenin at the adult stage.
Discussion
In this study, we made MSTN mutant medaka (mstnC315Y), corre-
sponding to naturally occurring mutation in double-muscled Pied-
montese cattle (Kambadur et al., 1997), by using the TILLING
method (Taniguchi et al., 2006). mstnC315Y exhibited a double-
muscling phenotype with hyperplasia and hypertrophy. Hyperplasia
and up-regulation of both Myf-5 and MyoD mRNA occurred at the
stage from the post-juvenile to the early adult and then the hypertro-
phy and up-regulation of myogenin mRNA at the adult stage. These
results suggested that loss of the MSTN function in themstnC315Y in-
duced hyperplasia due to up-regulation of both Myf-5 and MyoD
from the post-juvenile stage to the early adult stage, and then hyper-
trophy due to up-regulation of myogenin at the late adult stage. The
hyperplasia and hypertrophy caused an increased body weight in
the mstnC315Y. This is the ﬁrst report that loss of the MSTN function
in ﬁsh causes double-muscling phenotype with both hyperplasia
and hypertrophy.
The cysteine residue at the 315-position of MSTN peptide is
known to be one of the important amino acid residues involved in
forming the cysteine knot structure in members of the TGF-β super-
family (Berry et al., 2002). The structure is needed for a functional
homodimer, which binds activin receptor type IIB (ActRIIB) to elicit
a biological function (Lee and McPherron, 2001). Therefore, a point
mutation at Cys (315) was fully conceivable to cause loss of the
MSTN function in mstnC315Y. To conﬁrm the loss of MSTN function,
we analyzed smad proteins in the muscle of mstnC315Y and WT me-
daka. Smads are essential intracellular transducers for the TGF-β sig-
naling pathway (Feng and Derynck, 2005; Shi and Massague, 2003).
In response to MSTN, Smad2 and/or 3 are phosphorylated and serve
as intermediate substances with the next signal transductions. In
mammals in vitro studies, induced Smad-phosphorylations varied
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Fig. 10. Proliferation signals of myogenic cells in skeletal muscle. Immunohistochemical analysis of muscle ﬁber in WT (A, C, E, and G) andmstnC315Y (B, D, F and H) medaka. Cross-
sectional area is described in Fig. 5B. Proliferation cell nuclear antigens (PCNA) were detected as described in the Materials and methods. (A to D) Muscle ﬁbers at post-juvenile stage
(SL=15mm). (A and B) PCNA-positive nuclei of cells were colored with diaminobenzine (brown). Some of the positive nuclei are indicated by arrowheads. (C and D) Sections adjacent
to panels A and B for each were stained with hematoxylin–eosin. PCNA-positive nuclei were more abundant inmstnC315Y than in WT at the post-juvenile stage. (E to H) Muscle ﬁbers
at adult stage (SL=20mm). (E and F) PCNA-positive nuclei were colored with diaminobenzine (brown). Some of the positive nuclei are indicated by arrowheads. (G and H) Sections
adjacent to panels E and F for each were stained with hematoxylin–eosin. There were few PCNA-positive nuclei in WT and mstnC315Y, suggesting that cell proliferation stopped in
both. Scale bars; 100 μm for (A) to (D); 200 μm for (E) to (H).
91S. Chisada et al. / Developmental Biology 359 (2011) 82–94with the type of cells. Recombinant MSTN protein induced only
Smad3 but not Smad2 phosphorylation in C2C12 myoblasts (Langley
et al., 2002), while both Smad2 and 3 phosphorylations occurred in
3T3-L1 adipocytes and 10T1/2 muscle ﬁbroblasts (Rebbapragada etal., 2003). The phosphorylated Smad2 and/or 3 led to arrest of differ-
entiation of these precursor cells in early differentiation. Additionally,
activation of the MSTN signaling pathway induced both Smad2 and 3
phosphorylations in muscle of adult mice, resulting in inhibition of
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Fig. 11. Gene expression analysis of myogenic regulatory factors of skeletal muscle.
Quantitative PCR analysis to measure mRNA levels of Myf-5, MyoD and myogenin in
WT (black columns) and mstnC315Y (white columns) medaka. Expression of elonga-
tion factor 1 alpha (EF-1α) was used to normalize all samples. All relative expressions
are represented as the ratio to that of WT medaka at each stage. (A) MRF expression at
the juvenile stage. There was no difference in MRF expression between WT and
mstnC315Y. (B) MRF expression at the post-juvenile stage. Myf-5 and MyoD in
mstnC315Ywere 3.4 and 1.6 times higher-expressed than those inWT. (C) MRF expres-
sion at the early adult stage. In addition to Myf-5 and MyoD, expression of myogenin in
mstnC315Y was increased. (D) MRF expression at the late adult stage. Only myogenin
was up-regulated in mstnC315Y with a 10 fold increase to WT. Values are means±
SEM (n=3, at all sample points). *pb0.05, **pb0.01 and ***pb0.001, respectively.
92 S. Chisada et al. / Developmental Biology 359 (2011) 82–94muscle hypertrophy (Sartori et al., 2009). In ﬁsh myogenesis, there
have been few reports on the relation between MSTN and Smad pro-
teins. The current study showed that nucleus extracts fromWTmeda-
ka muscles at the adult stage contained phosphorylated Smad2. In
contrast, mstnC315Y did not express phosphorylated Smad2 in the
muscle. Phosphorylated Smad3 was not detected in both extracts
(data not shown). These indicate that MSTN in muscle of medaka
has induced Smad2 phosphorylation at the adult stage, and then the
MSTN signaling pathway has been down-regulated in muscle of
mstnC315Y. MSTN-induced phosphorylation of smads in ﬁsh muscle
may be altered with developmental stages or ﬁsh species as well as
previous investigations in mammals. Thus, further studies will be re-
quired to resolve this question.One of the important factors in determining the body size in ﬁsh is
the number of muscle ﬁbers (Biga and Goetz, 2006; Veggetti et al.,
1990). Our growth analysis revealed that mstnC315Y had a larger
number of muscle ﬁbers than WT at the post-juvenile stage although
there was no difference in ﬁber size, indicating that the major cause
of the increased body weight in mstnC315Y at the post-juvenile
stage was only hyperplasia of muscle ﬁbers. The growth analysis
also showed that the body weight gain in mstnC315Y accelerated at
the late post-juvenile stage, giving rise to a substantial difference in
body weight between the two groups at the adult stage. One reason
for this phenomenon was that hyperplasia of muscle ﬁbers was main-
tained in mstnC315Y for a longer time. The proliferation of muscle ﬁ-
bers in WT stopped at the post-juvenile stage (5 wk post-hatching),
whereas that in mstnC315Y continued to the early-adult stage (8 wk
post-hatching). It was found that the extended period for prolifera-
tion of muscle ﬁbers resulted in a large number of ﬁbers inmstnC315Y
at the adult stage, affecting the body weight gain at the stage. Another
reason for the increasing difference in body weight was that
mstnC315Y exhibited hypertrophy of the muscle ﬁbers from 8 to
16 wk post-hatching compared with WT. The hypertrophy of ﬁbers
formed in mstnC315Y, the number of which had already been more
than that of WT, further led to the widening difference in body
weight. Therefore, our investigation throughout the life in medaka
showed that hypermorphosis of skeletal muscle in mstnC315Y was
due to the development of ﬁbers through the hyperplasia phase, fol-
lowed by the hypertrophy phase. This sequential hypermorphosis in
ﬁbers was responsible for the increased body weight of mstnC315Y.
Comparing themyogenesis inmstnC315YwithWT throughout life,
we found that muscle ﬁber development in medaka altered during
posthatch growth. Also in mammals, the differentiation pattern in
muscle ﬁber varies at development stages (Rowe and Goldspink,
1969;White et al., 2010); however, it should be noted that the chang-
ing point of the differentiation pattern differs between medaka and
mammals. In mammals, myogenic cell proliferation was stopped by
the MSTN signaling pathway at the late-prenatal stage (Amthor et
al., 2009; Manceau et al., 2008) and skeletal muscles achieve nearly
a full complement of muscle ﬁbers before birth (White et al., 2010).
Muscle growth at the postnatal stage can be accomplished by an in-
crease in the size of individual muscle ﬁbers, except for muscle repair.
Therefore in mammals, the differentiation pattern in muscle ﬁbers
changes prior to birth. Our study showed that muscle ﬁbers in meda-
ka were able to grow with an increase in number and size during
posthatch growth. Our data also shows that an increase in size of
muscle ﬁber occurred only in the adult stage in medaka, indicating
that the pattern of differentiation in muscle ﬁbers alters at the adult
stage. These indicate that myogenesis in medaka at the adult stage
corresponds to postnatal myogenesis in mammals in terms of the dif-
ferentiation pattern in ﬁbers. Based on the data in this study, we pro-
pose that medaka can be utilized to analyze myogenesis. As a model
animal of postnatal mammal, adult stage medaka can be utilized to
analyze myogenesis. Additionally, medaka from the embryonic stage
to the post-juvenile stage can be analyzed as a model animal of pre-
natal mammal. In ﬁsh, unlike mammals, muscle growth with both hy-
perplasia and hypertrophy can continue throughout life; however,
our data showed that the pattern of differentiation in muscle ﬁbers
of medaka was clearly differentiated. Therefore, if medaka as a
model ﬁsh is used to analyze ﬁsh myogenesis, it should be treated
with particular attention in regards to muscle ﬁber development.
In general, while tissues used in previous studies on mammalian
skeletal myogenesis had been muscles of arms or legs, skeletal muscle
in ﬁsh, except for ﬁn muscles, correspond to the body trunk in mam-
mals (Burke and Nowicki, 2003). Despite differences in the derivation
of muscle, we found that the MRF-mediated mechanism for muscle
ﬁber formation was conserved between skeletal muscle in medaka
and muscles of the limbs in mammals. In mammals, Myf-5 and
MyoD activate satellite cells (stem cells of myoblasts), and then
Appropriate number
of muscle fiber
Proper size
of muscle fiber
Juvenile Post-juvenile Early adult Late adult
MyostatinWT
Hyperplasia
with up-regulation of Myf-5 and MyoD
Hypertrophy
with up-regulation of myogenin
Juvenile Post-juvenile Early adult Late adult
mstnC315Y
Fig. 12.Model summarizing the inhibitory roles of MSTN in medaka during post-hatch growth. InmstnC315Y, hyperplasia occurred until the early adult stage with up-regulations of
Myf-5 and MyoD, and then hypertrophy was induced at the adult stage with up-regulation of myogenin. These indicate that MSTN in medaka plays an inhibitory role for hyperplastic
growth in muscle ﬁber during the juvenile and post-juvenile stages, followed by another inhibitory role for hypertrophic growth in muscle ﬁber at the adult stage.
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cells (Kablar et al., 1997; Olson and Klein, 1994). Myf-5 and MyoD
are also essential factors for the successful proliferation of muscle ﬁ-
bers during hyperplasia at postnatal myogenesis (Oldham et al.,
2001). Myogenin is critical in the late phase of muscle differentiation
speciﬁcally during the terminal differentiation at embryonic myogen-
esis and hypertrophy at postnatal myogenesis (Olson and Klein,
1994; Venuti et al., 1995). MRFs that were initially isolated in mam-
mals are also present in the genome of ﬁsh (Rescan, 2001). There
has been minimal study of relation between MRFs and myogenesis
at the posthatch stage, although several reports showed that MRFs
in ﬁsh play a role similar to those in mammals in embryonic somito-
genesis (Amali et al., 2004; Hinits et al., 2009). In our analysis, the ex-
pression pattern for MRF mRNAs in mstnC315Y was consistent with
the phenotype of muscle ﬁber development during posthatch growth.
Hyperplasia occurred with the high expression of both Myf-5 and
MyoD, and then hypertrophy occurred with the high expression of
myogenin. These indicate that MRFs in medaka could be available as
myogenic markers at the posthatch stage.
In this study we had expected that all MRFs in mstnC315Y were
expressed at high levels all through the developmental stages, since
muscle in ﬁsh can grow during the posthatch period and the MSTN sig-
naling pathway in mstnC315Y was fully inhibited. Contrary to our hy-
pothesis, the expression of Myf-5 and MyoD were suppressed and the
expression of myogenin was accelerated at the same time (from 8 to
16 wk post hatching) in mstnC315Y. At present, we have one explana-
tion to resolve the contradiction. It's to be noted that the insulin-like
growth factor (IGF) is also an important factor involved in myogenesis.
Florini et al. reported that IGF-1 regulated MRFs indirectly to enable
skeletal muscle development (Florini et al., 1996). That is, IGF-1-
activated the ERK (extracellular signal-related kinase) signaling path-
way inhibiting Myf-5 and MyoD expression and activity (Miyake et al.,
2007). Furthermore, IGF-1-induced PI3K/Akt (phosphoinositide-3 ki-
nase/ protein kinase B) signaling pathway promotes the expression of
myogenin (Miyake et al., 2007; Serra et al., 2007). Inﬁsh, several reports
have revealed that the expression of IGF-1 was up-regulated as sexual
maturation (puberty) began (Le Gac et al., 2001; Maestro et al., 1997;
Onuma et al., 2010). Since the period from 5 to 8 wk post-hatching inmedaka includes the onset of sexual maturation, it remains possible
that not only MSTN, but also IGF-1 is related with high expressions of
MRFs in mstnC315Y.
Finally, the roles of MSTN in muscle ﬁber development of medaka
are illustrated in Fig. 12. MSTN mutant medaka mstnC315Y shows a
body weight gain with hyperplasia and hypertrophy during posthatch
growth. Hyperplasia in mstnC315Y occurred from the post-juvenile
stage to the early adult stage with the high expression of both Myf-
5 and MyoD. Hypertrophy in mstnC315Y was induced at the adult
stage with the high expression of myogenin. These indicated that
MSTN in medaka plays a dual role in muscle ﬁber development,
which is an inhibitory role in hyperplastic growth at the post-
juvenile stage, and hypertrophic growth at the adult stage. In conclu-
sion, MSTN in medaka regulates the number and size of muscle ﬁber
in a temporally controlled manner during posthatch growth.
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